William DeVaul - 13 Jan 2023 Form 4 Insider Report for Morphic Holding, Inc.

Reporting relationship: General Counsel and Secretary
Issuer ticker: N/A
Reported as of: 13 Jan 2023
Net transaction value: -$35,805
SEC form: 4
Accepted by SEC: 18 Jan 2023, 18:09:18 UTC
Prior SEC filing: 19 Jan 2022
Next SEC filing: 25 May 2023
Source filing: View source filing
Reporting owner signature: /s/ Robert Farrell as attorney-in-fact for William D. DeVaul

Key filing fact

William DeVaul filed Form 4 for Morphic Holding, Inc. on 18 Jan 2023.

Key facts

This page summarizes William DeVaul's Form 4 filing for Morphic Holding, Inc..
5 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 18 Jan 2023, 18:09.

Change

Previous filing in this sequence was filed on 19 Jan 2022.
Current net transaction value: -$35,805.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MORF transaction

Common Stock

Options Exercise

Transaction value
Shares: +3,250
Change %: +15%
Price
Shares after: 24,908
Date: 14 Jan 2023
Ownership: Direct
Footnotes: F1

MORF transaction

Common Stock

Sale

Transaction value: $35,805
Shares: -1,169
Change %: -4.7%
Price: $30.63
Shares after: 23,739
Date: 14 Jan 2023
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MORF transaction Derivative

Stock Option (right to buy Common Stock)

Award

Transaction value: $0
Shares: +62,160
Change %
Price: $0.000000
Shares after: 62,160
Date: 13 Jan 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 62,160
Exercise price: $31.72
Footnotes: F3

MORF transaction Derivative

Restricted Stock Unit

Award

Transaction value: $0
Shares: +43,800
Change %
Price: $0.000000
Shares after: 43,800
Date: 13 Jan 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 43,800
Exercise price
Footnotes: F1, F4

MORF transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value: $0
Shares: +3,250
Change %: +50%
Price: $0.000000
Shares after: 9,750
Date: 14 Jan 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,250
Exercise price
Footnotes: F1, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.

Footnote F2

The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Footnote F3

The option vests as to 2.0833% of the total shares monthly, beginning February 13, 2023, with 100% of the total shares vested and exercisable on January 13, 2027, subject to the reporting person's provision of service to the issuer on each vesting date.

Footnote F4

The RSUs vest as to 25% of the total shares on each of January 13, 2024, January 13, 2025, January 13, 2026 and January 13, 2027, subject to the reporting person's provision of service to the issuer on each vesting date.

Footnote F5

The RSUs vest as to 25% of the total shares on each of January 14, 2023, January 14, 2024, January 14, 2025 and January 14, 2026, subject to the reporting person's provision of service to the issuer on each vesting date.